Vasorelaxant effect of a phosphodiesterase 3 inhibitor, olprinone, on isolated human radial artery

European Journal of Pharmacology

Volumn 396, Issue 1, 2000, Pages 43-47

  Adachi, Hideyuki ^a   Kamata, Satoshi ^b   Kodama, Kohtarou ^a   Nagakura, Tadashi ^a  

^a EISAI CO LTD   (Japan)

^b SAKAKIBARA HEART INSTITUTE   (Japan)

Author keywords

Olprinone; Phenylephrine; Phosphodiesterase 3; Radial artery

Indexed keywords

ISOENZYME; LOPRINONE; PHENYLEPHRINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; RADIAL ARTERY; VASODILATATION;

ENDOTHELIUM, VASCULAR; HUMANS; IMIDAZOLES; INDICATORS AND REAGENTS; ISOENZYMES; MUSCLE, SMOOTH, VASCULAR; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PYRIDONES; RADIAL ARTERY; VASODILATOR AGENTS;

EID: 0034640482     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00190-4     Document Type: Article

References (16)

1. Acar C., Jebara V.A., Portoghese M., Beyssen B., Pagny J.Y., Grare P., Chachques J.C., Fabiani J.-N., Deloche A., Guermonprez J.L., Carpenier A.F. Revival of the radial artery for coronary artery bypass grafting. Ann. Thorac. Surg. 54:1992;652-660.
2. Adachi H., Tanaka H. Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure. J. Cardiovasc. Pharmacol. 29:1997;763-771.
3. Cable D.G., Caccitolo J.A., Pearson P.J., O'Brien T., Mullany C.J., Daly R.C., Orszulak T.A., Schaff H.V. New approaches to prevention and treatment of radial artery graft vasospasm. Circulation. 98:1998;II-15-II-22.
4. Carpentier A., Guermonprez J.L., Deloche A., Frechette C., Dubost C. The aorta-to-coronary radial artery bypass graft: a technique avoiding pathological changes in grafts. Ann. Thorac. Surg. 16:1973;111-121.
5. Ito M., Nishikawa M., Fujioka M., Miyahara M., Isaka N., Shiku H., Nakano T. Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021. Cell. Signal. 8:1996;575-581.
6. 2+-independent vasorelaxation induced by cardiotonic phosphodiesterase inhibitors. Eur. J. Pharmacol. 240:1993;57-66.
7. Liu J.J., Doolan L.A., Xie B., Chen J.R., Buxton B.F. Direct vasodilator effect of milrinone, an inotropic drug, on arterial coronary bypass grafts. J. Thorac. Cardiovasc. Surg. 113:1997;108-113.
8. Manasse E., Sperti G., Suma H., Canosa C., Kol A., Martinelli L., Schiavello R., Crea F., Maseri A., Possati G.F. Use of the radial artery for myocardial revascularization. Ann. Thorac. Surg. 62:1996;1076-1083.
9. Miyahara M., Ito M., Itoh H., Shiraishi T., Isaka N., Konishi T., Nakano T. Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021. Eur. J. Pharmacol. 284:1995;25-33.
10. Ogawa T., Ohhara H., Tsunoda H., Kuroki J., Shoji T. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate: first communication: studies on isolated guinea pig cardiac muscles. Arzneim.-Forsch. Drug Res. 39:1989;33-37.
11. Ohhara H., Ogawa T., Takeda M., Katoh H., Daiku Y., Igarashi T. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate: second communication: studies in dogs. Arzneim-Forsch/Drug Res. 39:1989;38-45.
12. Ohoka M., Honda M., Morioka S. Effects of E-1020, a new cyclic AMP-specific phosphodiesterase inhibitor, on cyclic AMP and cytosolic free calcium of cultured vascular smooth muscle cells. Jpn. Circ. J. 54:1990;679-687.
13. Orime Y., Shiono M., Hata H., Yagi S., Tsukamoto S., Okumura H., Kimura S., Hata M., Sezai A., Obata M., Sezai Y. Effects of phosphodiesterase inhibitors after coronary artery bypass grafting. Jpn. Circ. J. 63:1999;117-122.
14. Saeki T., Saito I. Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta. Biochem. Pharmacol. 46:1993;833-839.
15. Sugioka M., Ito M., Masuoka H., Ichikawa K., Konishi T., Tanaka T., Nakano T. Identification and characterization of isoenzymes of cyclic nucleotide phosphodiesterase in human kidney and heart, and the effects of new cardiotonic agents on these isoenzymes. Naunyn.-Schmiedeberg's. Arch. Pharmacol. 350:1994;284-293.
16. Thorin-trescases N., Dimitri W.R., Dominiczak A.F., Hamilton C.A., Reid J.L. Vasorelaxant properties of isolated human internal mammary arteries and saphenous veins: comparative effects of milrinone and sodium nitroprusside. J. Cardiovasc. Pharmacol. 22:1993;673-680.